Humankind US Stock ETF (HKND) is an indexed equity exchange-traded fund that seeks to track the total return performance of the Humankind US Equity Index before fees and expenses. The fund, issued by Humankind Investments LLC and managed as the first Benefit Corporation ETF, invests primarily in common stocks of domestic U.S. companies selected and weighted based on their "Humankind Value" scores, which incorporate investor value, consumer value, employee value, societal value, and supply chain relationship adjustments; it features heavy sector allocations to health care (40%), consumer staples (15.48%), and information technology (12.17%), with approximately 999 holdings subject to quarterly rebalancing by index calculator Solactive AG. Traded on NYSE Arca with a low expense ratio of 0.11%, CUSIP 444869101, and net assets of $141.57 million as of late November 2025, the ETF targets investors seeking portfolios aligned with positive economic impacts on humankind.
Launched on February 24, 2021, and headquartered with Humankind Investments LLC in the United States, the ETF operates exclusively in U.S. equity markets without notable subsidiaries or parent entities beyond its investment adviser relationship.
In a significant recent development, Humankind Investments announced the liquidation of the ETF on October 17, 2025, citing insufficient assets under management; the last trading day is scheduled for December 1, 2025, with final cash distributions to remaining shareholders on December 8, 2025, after which the fund will terminate, potentially resulting in taxable events for investors. No major partnerships, acquisitions, funding rounds, or new product launches were reported in the prior 1-2 years leading up to this operational wind-down.